What is Invivyd's operating income?

Invivyd's total operating income in 2025 was -$55.56 million, based on the following breakdown: Total Gross Profit: $49.68 million Total Operating Expenses: $105.24 million

Invivyd (IVVD) Financials

$0.80 -0.03 (-3.17%)

Closing price 04:00 PM Eastern

Extended Trading

$0.82 +0.02 (+2.28%)

As of 07:57 PM Eastern

Compare

Annual Income Statements for Invivyd

This table shows Invivyd's income and expenses over time, based on annual financial data. All values are USD millions unless otherwise specified.

Metric	2021	2022	2023	2024	2025
Period end date	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025
Net Income / (Loss) Attributable to Common Shareholders	-227	-241	-199	-170	-52
Consolidated Net Income / (Loss)	-227	-241	-199	-170	-52
Net Income / (Loss) Continuing Operations	-227	-241	-199	-170	-52
Total Pre-Tax Income	-227	-241	-199	-170	-52
Total Operating Income	-227	-248	-213	-177	-56
Total Gross Profit	0.00	0.00	0.00	24	50
Total Revenue	0.00	0.00	0.00	25	53
Operating Revenue	-	-	0.00	25	53
Total Cost of Revenue	0.00	0.00	0.00	1.62	3.75
Operating Cost of Revenue	-	-	0.00	1.62	3.75
Total Operating Expenses	227	248	213	201	105
Selling, General & Admin Expense	37	47	49	63	67
Research & Development Expense	190	184	164	137	38
Total Other Income / (Expense), net	0.12	6.71	14	6.95	3.07
Other Income / (Expense), net	0.12	6.71	14	6.95	3.07
Basic Earnings per Share	($5.32)	($2.23)	($1.81)	($1.43)	($0.30)
Weighted Average Basic Shares Outstanding	42.62M	108.27M	109.53M	118.56M	172.21M
Diluted Earnings per Share	($5.32)	($2.23)	($1.81)	($1.43)	($0.30)
Weighted Average Diluted Shares Outstanding	42.62M	108.27M	109.53M	118.56M	172.21M
Weighted Average Basic & Diluted Shares Outstanding	42.62M	109.19M	119.22M	119.96M	282.59M

This table shows Invivyd's income and expenses over time, based on quarterly financial data. All values are USD millions unless otherwise specified.

Metric	Q3 2023	Q4 2023	Q1 2024	Q2 2024	Q3 2024	Q4 2024	Q1 2025	Q2 2025	Q3 2025	Q4 2025	Q1 2026
Period end date	9/30/2023	12/31/2023	3/31/2024	6/30/2024	9/30/2024	12/31/2024	3/31/2025	6/30/2025	9/30/2025	12/31/2025	3/31/2026
Net Income / (Loss) Attributable to Common Shareholders	-39	-74	-43	-47	-61	-18	-16	-15	-10	-11	-41
Consolidated Net Income / (Loss)	-39	-74	-43	-47	-61	-18	-16	-15	-10	-11	-41
Net Income / (Loss) Continuing Operations	-39	-74	-43	-47	-61	-18	-16	-15	-10	-11	-41
Total Pre-Tax Income	-39	-74	-43	-47	-61	-18	-16	-15	-10	-11	-41
Total Operating Income	-43	-77	-46	-49	-62	-19	-17	-15	-11	-13	-43
Total Gross Profit	0.00	-	0.00	2.18	8.49	13	10	11	12	16	13
Total Revenue	0.00	-	0.00	2.26	9.30	14	11	12	13	17	14
Operating Revenue	-	-	0.00	2.26	9.30	14	11	12	13	17	14
Total Cost of Revenue	0.00	-	0.00	0.09	0.81	0.72	0.83	0.69	1.09	1.14	1.03
Operating Cost of Revenue	0.00	-	0.00	0.09	0.81	0.72	0.83	0.69	1.09	1.14	1.03
Total Operating Expenses	43	77	46	51	71	32	27	26	23	29	56
Selling, General & Admin Expense	13	15	15	21	13	14	17	17	15	19	25
Research & Development Expense	30	62	31	30	58	18	11	9.57	8.05	10	31
Total Other Income / (Expense), net	3.62	3.10	2.59	2.00	1.57	0.79	0.63	0.40	0.55	1.49	1.74
Other Income / (Expense), net	3.62	3.10	2.59	2.00	1.57	0.79	0.63	0.40	0.55	1.49	1.74
Basic Earnings per Share	($0.36)	($0.67)	($0.38)	($0.40)	($0.51)	($0.14)	($0.14)	($0.12)	($0.06)	$0.02	($0.13)
Weighted Average Basic Shares Outstanding	109.75M	109.53M	115.62M	119.36M	119.50M	118.56M	119.88M	120.02M	170.17M	172.21M	309.67M
Diluted Earnings per Share	($0.36)	($0.67)	($0.38)	($0.40)	($0.51)	($0.14)	($0.14)	($0.12)	($0.06)	$0.02	($0.13)
Weighted Average Diluted Shares Outstanding	109.75M	109.53M	115.62M	119.36M	119.50M	118.56M	119.88M	120.02M	170.17M	172.21M	309.67M
Weighted Average Basic & Diluted Shares Outstanding	110.11M	119.22M	119.32M	119.44M	119.62M	119.96M	119.96M	120.14M	233.12M	282.59M	294.61M

This table details how cash moves in and out of Invivyd's business through operations, investing, and financing, using annual figures. All values are USD millions unless otherwise specified.

Metric	2021	2022	2023	2024	2025
Period end date	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025
Net Change in Cash & Equivalents	427	-450	109	-131	157
Net Cash From Operating Activities	-185	-220	-173	-170	-58
Net Cash From Continuing Operating Activities	-185	-220	-173	-170	-58
Net Income / (Loss) Continuing Operations	-227	-241	-199	-170	-52
Consolidated Net Income / (Loss)	-227	-241	-199	-170	-52
Depreciation Expense	0.00	0.04	0.48	1.47	0.76
Amortization Expense	1.43	-1.60	0.43	1.65	1.35
Non-Cash Adjustments To Reconcile Net Income	18	39	19	18	12
Changes in Operating Assets and Liabilities, net	23	-16	5.89	-22	-20
Net Cash From Investing Activities	-51	-231	281	-0.14	-0.16
Net Cash From Continuing Investing Activities	-51	-231	281	-0.14	-0.16
Purchase of Property, Plant & Equipment	-0.08	-1.71	-0.62	-0.14	-0.16
Net Cash From Financing Activities	663	0.51	1.05	39	216
Net Cash From Continuing Financing Activities	663	0.51	1.05	39	216
Repurchase of Preferred Equity	-	-	-	0.00	-0.63
Issuance of Common Equity	331	0.27	0.24	40	183
Other Financing Activities, net	-3.39	0.24	0.81	-0.18	33
Effect of Exchange Rate Changes	-	-	0.00	0.01	0.00

This table details how cash moves in and out of Invivyd's business through operations, investing, and financing, using quarterly figures. All values are USD millions unless otherwise specified.

Metric	Q3 2023	Q4 2023	Q1 2024	Q2 2024	Q3 2024	Q4 2024	Q1 2025	Q2 2025	Q3 2025	Q4 2025	Q1 2026
Period end date	9/30/2023	12/31/2023	3/31/2024	6/30/2024	9/30/2024	12/31/2024	3/31/2025	6/30/2025	9/30/2025	12/31/2025	3/31/2026
Net Change in Cash & Equivalents	60	19	-11	-42	-41	-38	-21	-13	50	142	-43
Net Cash From Operating Activities	-35	-59	-50	-42	-41	-38	-21	-13	-8.25	-15	-42
Net Cash From Continuing Operating Activities	-35	-59	-50	-42	-41	-38	-21	-13	-8.16	-15	-42
Net Income / (Loss) Continuing Operations	-39	-74	-43	-47	-61	-18	-16	-15	-10	-11	-41
Consolidated Net Income / (Loss)	-39	-74	-43	-47	-61	-18	-16	-15	-10	-11	-41
Depreciation Expense	0.12	0.12	0.12	0.13	0.13	1.08	0.31	0.15	0.15	0.15	0.17
Amortization Expense	-1.30	5.53	0.40	0.39	0.43	0.43	0.43	0.35	0.28	0.29	0.35
Non-Cash Adjustments To Reconcile Net Income	5.03	4.34	5.38	8.49	2.86	1.39	2.83	3.18	3.37	2.57	2.75
Changes in Operating Assets and Liabilities, net	0.24	4.42	-13	-3.36	16	-22	-8.40	-2.42	-1.49	-7.39	-3.58
Net Cash From Investing Activities	95	78	-0.14	-	-0.01	0.01	-0.14	-0.01	-	-	-0.73
Net Cash From Continuing Investing Activities	95	78	-0.14	-	-0.01	0.01	-0.14	-0.01	-	-	-0.73
Purchase of Property, Plant & Equipment	-	-	-0.14	-	-0.01	0.01	-0.14	-0.01	-	-	-0.73
Net Cash From Financing Activities	0.09	0.14	39	0.09	0.06	0.08	0.01	0.13	58	157	-0.10
Net Cash From Continuing Financing Activities	0.09	0.14	39	0.09	0.06	0.08	0.01	0.13	58	157	-0.10
Repurchase of Preferred Equity	-	-	-	-	-	-	0.00	-	-	-0.42	-0.23
Issuance of Common Equity	0.06	0.04	39	0.08	-39	39	0.04	0.08	54	129	0.14
Other Financing Activities, net	0.04	0.10	-0.27	0.02	39	-39	-0.03	0.05	4.43	29	-0.00
Effect of Exchange Rate Changes	-	-	0.00	-	-	-	-0.01	-	-	-	0.00

This table presents Invivyd's assets and liabilities at the end of each period, using annual balance sheet data. All values are USD millions unless otherwise specified.

Metric	2020	2021	2022	2023	2024	2025
Period end date	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025
Total Assets	117	620	383	229	130	277
Total Current Assets	117	617	377	225	101	247
Cash & Equivalents	115	542	92	201	69	227
Accounts Receivable	-	-	-	0.00	11	14
Prepaid Expenses	2.39	25	4.93	24	20	6.86
Plant, Property, & Equipment, net	0.00	0.08	2.28	1.90	1.51	1.37
Total Noncurrent Assets	0.00	3.30	3.97	2.40	27	28
Other Noncurrent Operating Assets	0.00	3.30	3.97	2.40	27	28
Total Liabilities & Shareholders' Equity	117	620	383	229	130	277
Total Liabilities	13	62	27	52	62	35
Total Current Liabilities	13	62	25	50	62	34
Accounts Payable	8.15	5.78	1.52	7.95	10	14
Accrued Expenses	4.92	56	22	41	50	19
Other Current Liabilities	-	0.00	1.60	1.48	1.33	1.37
Total Noncurrent Liabilities	0.01	0.01	2.17	1.42	0.00	1.18
Other Noncurrent Operating Liabilities	0.01	0.01	2.17	1.42	0.00	1.18
Commitments & Contingencies	0.00	0.00	0.00	0.00	0.00	0.00
Total Equity & Noncontrolling Interests	-65	558	356	177	68	242
Total Preferred & Common Equity	-65	558	356	177	68	242
Preferred Stock	-	0.00	0.00	0.00	0.00	0.00
Total Common Equity	-65	558	356	177	68	242
Common Stock	0.16	850	890	910	970	1,196
Retained Earnings	-65	-292	-533	-732	-902	-954
Accumulated Other Comprehensive Income / (Loss)	-	-0.01	-0.27	-0.01	-0.01	-0.04

This table presents Invivyd's assets and liabilities at the end of each period, using quarterly balance sheet data. All values are USD millions unless otherwise specified.

Metric	Q3 2023	Q1 2024	Q2 2024	Q3 2024	Q1 2025	Q2 2025	Q3 2025	Q1 2026
Period end date	9/30/2023	3/31/2024	6/30/2024	9/30/2024	3/31/2025	6/30/2025	9/30/2025	3/31/2026
Total Assets	275	215	177	162	104	89	139	242
Total Current Assets	270	210	173	151	76	59	110	205
Cash & Equivalents	182	189	148	107	48	35	85	184
Accounts Receivable	-	-	2.89	8.15	8.56	8.70	9.85	12
Prepaid Expenses	5.22	20	17	9.01	19	16	15	9.11
Plant, Property, & Equipment, net	2.00	1.90	1.77	1.64	1.52	1.39	1.26	1.69
Total Noncurrent Assets	2.81	3.68	2.56	9.18	26	28	28	35
Other Noncurrent Operating Assets	2.81	3.68	2.56	9.18	26	28	28	35
Total Liabilities & Shareholders' Equity	275	215	177	162	104	89	139	242
Total Liabilities	28	37	37	79	50	46	46	39
Total Current Liabilities	27	36	37	79	50	44	44	32
Accounts Payable	9.17	1.17	7.50	18	8.74	18	18	2.02
Accrued Expenses	16	34	27	59	40	25	25	28
Other Current Liabilities	1.67	1.17	0.70	1.43	0.93	1.09	1.12	1.65
Total Noncurrent Liabilities	1.63	0.63	0.00	0.22	0.00	1.90	1.59	7.03
Other Noncurrent Operating Liabilities	1.63	0.63	0.00	0.22	-	1.90	1.59	7.03
Commitments & Contingencies	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Total Equity & Noncontrolling Interests	246	178	141	83	54	43	93	203
Total Preferred & Common Equity	246	178	141	83	54	43	93	203
Preferred Stock	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Total Common Equity	246	178	141	83	54	43	93	203
Common Stock	905	954	963	967	972	976	1,037	1,199
Retained Earnings	-658	-776	-823	-884	-918	-933	-943	-996
Accumulated Other Comprehensive Income / (Loss)	-0.00	-0.01	-0.01	-0.02	-0.01	-0.04	-0.04	-0.04

This table displays calculated financial ratios and metrics derived from Invivyd's official financial filings.

Metric	2021	2022	2023	2024	2025
Period end date	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025
DEI Shares Outstanding	111,251,660.00	108,982,401.00	110,114,960.00	119,616,035.00	233,122,834.00
DEI Adjusted Shares Outstanding	111,251,660.00	108,982,401.00	110,114,960.00	119,616,035.00	233,122,834.00
DEI Earnings Per Adjusted Shares Outstanding	-2.04	-2.21	-1.80	-1.42	-0.23
Growth Metrics	-	-	-	-	-
Revenue Growth	0.00%	0.00%	0.00%	0.00%	110.47%
EBITDA Growth	0.00%	-7.77%	18.59%	15.64%	69.80%
EBIT Growth	0.00%	-6.41%	17.68%	14.46%	69.11%
NOPAT Growth	0.00%	-9.31%	14.22%	16.87%	68.59%
Net Income Growth	0.00%	-6.41%	17.68%	14.46%	69.11%
EPS Growth	0.00%	58.08%	18.83%	20.99%	79.02%
Operating Cash Flow Growth	0.00%	-19.08%	21.28%	1.54%	65.90%
Free Cash Flow Firm Growth	0.00%	0.00%	25.77%	-2.40%	61.73%
Invested Capital Growth	0.00%	52.03%	-44.64%	92.19%	920.50%
Revenue Q/Q Growth	0.00%	0.00%	0.00%	119.51%	6.77%
EBITDA Q/Q Growth	0.00%	12.45%	-12.21%	23.44%	11.10%
EBIT Q/Q Growth	0.00%	13.75%	-17.15%	24.52%	12.32%
NOPAT Q/Q Growth	0.00%	12.33%	-15.49%	24.54%	10.72%
Net Income Q/Q Growth	0.00%	13.75%	-17.15%	24.52%	12.32%
EPS Q/Q Growth	0.00%	0.00%	-16.77%	27.04%	34.78%
Operating Cash Flow Q/Q Growth	0.00%	10.50%	-7.34%	11.26%	27.59%
Free Cash Flow Firm Q/Q Growth	0.00%	0.00%	6.60%	8.55%	26.30%
Invested Capital Q/Q Growth	0.00%	61.14%	-26.04%	92.37%	83.32%
Profitability Metrics	-	-	-	-	-
Gross Margin	0.00%	0.00%	0.00%	93.63%	92.99%
EBITDA Margin	0.00%	0.00%	0.00%	-657.15%	-94.30%
Operating Margin	0.00%	0.00%	0.00%	-696.80%	-103.99%
EBIT Margin	0.00%	0.00%	0.00%	-669.42%	-98.25%
Profit (Net Income) Margin	0.00%	0.00%	0.00%	-669.42%	-98.25%
Tax Burden Percent	100.00%	100.00%	100.00%	100.00%	100.00%
Interest Burden Percent	100.00%	100.00%	100.00%	100.00%	100.00%
Effective Tax Rate	0.00%	0.00%	0.00%	0.00%	0.00%
Return on Invested Capital (ROIC)	0.00%	0.00%	0.00%	0.00%	-596.46%
ROIC Less NNEP Spread (ROIC-NNEP)	0.00%	0.00%	0.00%	0.00%	-587.27%
Return on Net Nonoperating Assets (RNNOA)	0.00%	0.00%	0.00%	0.00%	562.49%
Return on Equity (ROE)	-68.48%	-52.81%	-74.48%	-138.71%	-33.96%
Cash Return on Invested Capital (CROIC)	0.00%	0.00%	0.00%	0.00%	-374.07%
Operating Return on Assets (OROA)	0.00%	0.00%	0.00%	-94.75%	-25.83%
Return on Assets (ROA)	0.00%	0.00%	0.00%	-94.75%	-25.83%
Return on Common Equity (ROCE)	-50.95%	-52.81%	-74.48%	-138.71%	-33.96%
Return on Equity Simple (ROE_SIMPLE)	-40.64%	-67.79%	-111.93%	0.00%	0.00%
Net Operating Profit after Tax (NOPAT)	-159	-174	-149	-124	-39
NOPAT Margin	0.00%	0.00%	0.00%	-487.76%	-72.80%
Net Nonoperating Expense Percent (NNEP)	-11.49%	-14.05%	-17.36%	-34.16%	-9.19%
Return On Investment Capital (ROIC_SIMPLE)	-	-	-83.92%	-183.32%	-16.10%
Cost of Revenue to Revenue	0.00%	0.00%	0.00%	6.37%	7.01%
SG&A Expenses to Revenue	0.00%	0.00%	0.00%	249.72%	125.28%
R&D to Revenue	0.00%	0.00%	0.00%	540.71%	71.70%
Operating Expenses to Revenue	0.00%	0.00%	0.00%	790.43%	196.98%
Earnings before Interest and Taxes (EBIT)	-227	-241	-199	-170	-52
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)	-225	-243	-198	-167	-50
Valuation Ratios	-	-	-	-	-
Price to Book Value (P/BV)	1.45	0.46	2.44	0.78	2.38
Price to Tangible Book Value (P/TBV)	1.45	0.46	2.44	0.78	2.38
Price to Revenue (P/Rev)	0.00	0.00	0.00	2.09	10.78
Price to Earnings (P/E)	0.00	0.00	0.00	0.00	0.00
Dividend Yield	0.00%	0.00%	0.00%	0.00%	0.00%
Earnings Yield	0.00%	0.00%	0.00%	0.00%	0.00%
Enterprise Value to Invested Capital (EV/IC)	0.00	0.00	0.00	0.00	23.51
Enterprise Value to Revenue (EV/Rev)	0.00	0.00	0.00	0.00	6.53
Enterprise Value to EBITDA (EV/EBITDA)	0.00	0.00	0.00	0.00	0.00
Enterprise Value to EBIT (EV/EBIT)	0.00	0.00	0.00	0.00	0.00
Enterprise Value to NOPAT (EV/NOPAT)	0.00	0.00	0.00	0.00	0.00
Enterprise Value to Operating Cash Flow (EV/OCF)	0.00	0.00	0.00	0.00	0.00
Enterprise Value to Free Cash Flow (EV/FCFF)	0.00	0.00	0.00	0.00	0.00
Leverage & Solvency	-	-	-	-	-
Debt to Equity	0.00	0.00	0.00	0.00	0.00
Long-Term Debt to Equity	0.00	0.00	0.00	0.00	0.00
Financial Leverage	-1.06	-1.05	-1.07	-1.10	-0.96
Leverage Ratio	1.11	1.10	1.15	1.46	1.31
Compound Leverage Factor	1.11	1.10	1.15	1.46	1.31
Debt to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%
Short-Term Debt to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%
Long-Term Debt to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%
Preferred Equity to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%
Noncontrolling Interests to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%
Common Equity to Total Capital	100.00%	100.00%	100.00%	100.00%	100.00%
Debt to EBITDA	0.00	0.00	0.00	0.00	0.00
Net Debt to EBITDA	0.00	0.00	0.00	0.00	0.00
Long-Term Debt to EBITDA	0.00	0.00	0.00	0.00	0.00
Debt to NOPAT	0.00	0.00	0.00	0.00	0.00
Net Debt to NOPAT	0.00	0.00	0.00	0.00	0.00
Long-Term Debt to NOPAT	0.00	0.00	0.00	0.00	0.00
Altman Z-Score	7.01	0.68	-1.38	-13.01	5.44
Noncontrolling Interest Sharing Ratio	25.60%	0.00%	0.00%	0.00%	0.00%
Liquidity Ratios	-	-	-	-	-
Current Ratio	9.94	15.06	4.47	1.62	7.24
Quick Ratio	9.53	14.86	3.99	1.29	7.04
Cash Flow Metrics	-	-	-	-	-
Free Cash Flow to Firm (FCFF)	0.00	-191	-142	-145	-56
Operating Cash Flow to CapEx	-219,923.81%	-12,902.46%	-28,156.75%	-121,779.29%	-37,506.45%
Free Cash Flow to Firm to Interest Expense	0.00	0.00	0.00	0.00	0.00
Operating Cash Flow to Interest Expense	0.00	0.00	0.00	0.00	0.00
Operating Cash Flow Less CapEx to Interest Expense	0.00	0.00	0.00	0.00	0.00
Efficiency Ratios	-	-	-	-	-
Asset Turnover	0.00	0.00	0.00	0.14	0.26
Accounts Receivable Turnover	0.00	0.00	0.00	0.00	4.30
Inventory Turnover	0.00	0.00	0.00	0.00	0.00
Fixed Asset Turnover	0.00	0.00	0.00	14.91	37.19
Accounts Payable Turnover	0.00	0.00	0.00	0.18	0.31
Days Sales Outstanding (DSO)	0.00	0.00	0.00	0.00	84.80
Days Inventory Outstanding (DIO)	0.00	0.00	0.00	0.00	0.00
Days Payable Outstanding (DPO)	0.00	0.00	0.00	2,075.51	1,178.29
Cash Conversion Cycle (CCC)	0.00	0.00	0.00	-2,075.51	-1,093.49
Capital & Investment Metrics	-	-	-	-	-
Invested Capital	-33	-16	-23	-1.81	15
Invested Capital Turnover	0.00	0.00	0.00	-2.03	8.19
Increase / (Decrease) in Invested Capital	0.00	17	-7.15	21	17
Enterprise Value (EV)	216	-209	233	-16	349
Market Capitalization	808	163	434	53	576
Book Value per Share	$5.02	$3.27	$1.61	$0.56	$1.04
Tangible Book Value per Share	$5.02	$3.27	$1.61	$0.56	$1.04
Total Capital	558	356	177	68	242
Total Debt	0.00	0.00	0.00	0.00	0.00
Total Long-Term Debt	0.00	0.00	0.00	0.00	0.00
Net Debt	-591	-372	-201	-69	-227
Capital Expenditures (CapEx)	0.08	1.71	0.62	0.14	0.16
Debt-free, Cash-free Net Working Capital (DFCFNWC)	-37	-20	-26	-31	-13
Debt-free Net Working Capital (DFNWC)	555	352	175	39	213
Net Working Capital (NWC)	555	352	175	39	213
Net Nonoperating Expense (NNE)	68	68	50	46	14
Net Nonoperating Obligations (NNO)	-591	-372	-201	-69	-227
Total Depreciation and Amortization (D&A)	1.43	-1.56	0.91	3.11	2.11
Debt-free, Cash-free Net Working Capital to Revenue	0.00%	0.00%	0.00%	-120.72%	-25.05%
Debt-free Net Working Capital to Revenue	0.00%	0.00%	0.00%	152.48%	399.25%
Net Working Capital to Revenue	0.00%	0.00%	0.00%	152.48%	399.25%
Earnings Adjustments	-	-	-	-	-
Adjusted Basic Earnings per Share	$0.00	($2.23)	($1.81)	($1.43)	($0.30)
Adjusted Weighted Average Basic Shares Outstanding	109.68M	108.27M	109.53M	118.56M	172.21M
Adjusted Diluted Earnings per Share	$0.00	($2.23)	($1.81)	($1.43)	($0.30)
Adjusted Weighted Average Diluted Shares Outstanding	109.68M	108.27M	109.53M	118.56M	172.21M
Adjusted Basic & Diluted Earnings per Share	$0.00	$0.00	$0.00	$0.00	$0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding	42.62M	109.19M	119.22M	119.96M	282.59M
Normalized Net Operating Profit after Tax (NOPAT)	-159	-174	-149	-124	-39
Normalized NOPAT Margin	0.00%	0.00%	0.00%	-487.76%	-72.80%
Pre Tax Income Margin	0.00%	0.00%	0.00%	-669.42%	-98.25%
Debt Service Ratios	-	-	-	-	-
EBIT to Interest Expense	0.00	0.00	0.00	0.00	0.00
NOPAT to Interest Expense	0.00	0.00	0.00	0.00	0.00
EBIT Less CapEx to Interest Expense	0.00	0.00	0.00	0.00	0.00
NOPAT Less CapEx to Interest Expense	0.00	0.00	0.00	0.00	0.00
Payout Ratios	-	-	-	-	-
Dividend Payout Ratio	0.00%	0.00%	0.00%	0.00%	0.00%
Augmented Payout Ratio	0.00%	0.00%	0.00%	0.00%	0.00%

This table displays calculated financial ratios and metrics derived from Invivyd's official financial filings.

Metric	Q3 2023	Q4 2023	Q1 2024	Q2 2024	Q3 2024	Q4 2024	Q1 2025	Q2 2025	Q3 2025	Q4 2025	Q1 2026
Period end date	9/30/2023	12/31/2023	3/31/2024	6/30/2024	9/30/2024	12/31/2024	3/31/2025	6/30/2025	9/30/2025	12/31/2025	3/31/2026
DEI Shares Outstanding	109,755,624.00	110,114,960.00	119,221,230.00	119,315,787.00	119,442,635.00	119,616,035.00	119,961,445.00	119,961,445.00	120,142,811.00	233,122,834.00	282,594,729.00
DEI Adjusted Shares Outstanding	109,755,624.00	110,114,960.00	119,221,230.00	119,315,787.00	119,442,635.00	119,616,035.00	119,961,445.00	119,961,445.00	120,142,811.00	233,122,834.00	282,594,729.00
DEI Earnings Per Adjusted Shares Outstanding	-0.36	-0.67	-0.36	-0.40	-0.51	-0.15	-0.14	-0.12	-0.09	-0.05	-0.15
Growth Metrics	-	-	-	-	-	-	-	-	-	-	-
Revenue Growth	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	420.58%	41.17%	24.51%	21.59%
EBITDA Growth	10.03%	-46.30%	-15.01%	9.68%	-48.14%	75.11%	63.81%	69.71%	83.32%	37.17%	-162.92%
EBIT Growth	12.52%	-65.24%	-23.14%	5.93%	-54.00%	74.96%	62.55%	68.97%	82.76%	39.98%	-154.16%
NOPAT Growth	9.02%	-59.20%	-17.96%	8.59%	-44.71%	74.95%	63.28%	69.42%	82.31%	34.71%	-154.91%
Net Income Growth	12.52%	-65.24%	-23.14%	5.93%	-54.00%	74.96%	62.55%	68.97%	82.76%	39.98%	-154.16%
EPS Growth	14.29%	-63.41%	-18.75%	13.04%	-41.67%	79.10%	63.16%	70.00%	88.24%	114.29%	7.14%
Operating Cash Flow Growth	37.03%	-24.97%	-21.93%	-11.25%	-16.17%	36.51%	57.92%	68.03%	79.91%	58.91%	-97.42%
Free Cash Flow Firm Growth	-132.50%	8.90%	70.00%	45.48%	27.72%	25.23%	-2.69%	41.80%	-3.21%	26.92%	-49.35%
Invested Capital Growth	55.40%	-44.64%	-63.05%	57.08%	-28.95%	92.19%	155.75%	208.91%	134.17%	920.50%	211.27%
Revenue Q/Q Growth	0.00%	0.00%	0.00%	0.00%	310.78%	48.60%	-18.21%	4.26%	11.39%	31.06%	-20.13%
EBITDA Q/Q Growth	21.49%	-67.40%	36.81%	-8.75%	-28.77%	71.87%	8.13%	8.96%	29.09%	-5.94%	-284.46%
EBIT Q/Q Growth	21.48%	-86.75%	40.95%	-8.62%	-28.56%	69.64%	11.68%	10.00%	28.58%	-5.73%	-273.98%
NOPAT Q/Q Growth	20.07%	-78.24%	39.95%	-6.85%	-26.53%	69.14%	12.00%	11.00%	26.81%	-13.90%	-243.58%
Net Income Q/Q Growth	21.48%	-86.75%	40.95%	-8.62%	-28.56%	69.64%	11.68%	10.00%	28.58%	-5.73%	-273.98%
EPS Q/Q Growth	21.74%	-86.11%	43.28%	-5.26%	-27.50%	72.55%	0.00%	14.29%	50.00%	133.33%	-750.00%
Operating Cash Flow Q/Q Growth	5.45%	-67.57%	15.24%	17.16%	1.28%	8.42%	43.82%	37.05%	37.97%	-87.33%	-169.89%
Free Cash Flow Firm Q/Q Growth	34.50%	12.09%	39.77%	-57.22%	13.16%	9.07%	17.28%	10.91%	-54.00%	35.61%	-69.05%
Invested Capital Q/Q Growth	-9.01%	-26.04%	53.01%	33.53%	-227.50%	92.37%	435.41%	29.86%	2.75%	83.32%	27.24%
Profitability Metrics	-	-	-	-	-	-	-	-	-	-	-
Gross Margin	0.00%	0.00%	0.00%	96.11%	91.33%	94.76%	92.62%	94.19%	91.71%	93.37%	92.49%
EBITDA Margin	0.00%	0.00%	0.00%	-2,064.18%	-647.10%	-122.48%	-137.57%	-120.12%	-76.46%	-61.81%	-297.49%
Operating Margin	0.00%	0.00%	0.00%	-2,175.22%	-670.01%	-139.14%	-149.70%	-127.78%	-83.96%	-72.96%	-313.85%
EBIT Margin	0.00%	0.00%	0.00%	-2,086.88%	-653.11%	-133.45%	-144.10%	-124.38%	-79.75%	-64.33%	-301.22%
Profit (Net Income) Margin	0.00%	0.00%	0.00%	-2,086.88%	-653.11%	-133.45%	-144.10%	-124.38%	-79.75%	-64.33%	-301.22%
Tax Burden Percent	100.00%	100.00%	100.00%	100.00%	100.00%	100.00%	100.00%	100.00%	100.00%	100.00%	100.00%
Interest Burden Percent	100.00%	100.00%	100.00%	100.00%	100.00%	100.00%	100.00%	100.00%	100.00%	100.00%	100.00%
Effective Tax Rate	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Return on Invested Capital (ROIC)	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	-12,816.30%	0.00%	-418.49%	-983.15%
ROIC Less NNEP Spread (ROIC-NNEP)	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	-12,811.80%	0.00%	-416.95%	-973.50%
Return on Net Nonoperating Assets (RNNOA)	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	12,766.75%	0.00%	399.35%	878.99%
Return on Equity (ROE)	-54.35%	-74.48%	-81.87%	-96.56%	-136.59%	-138.71%	-122.69%	-49.56%	-67.94%	-19.13%	-104.15%
Cash Return on Invested Capital (CROIC)	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	-1,982.50%	-1,199.75%	-930.41%	-374.07%	-561.26%
Operating Return on Assets (OROA)	0.00%	0.00%	0.00%	-19.18%	-34.58%	-18.89%	-33.12%	-43.14%	-26.51%	-16.92%	-97.42%
Return on Assets (ROA)	0.00%	0.00%	0.00%	-19.18%	-34.58%	-18.89%	-33.12%	-43.14%	-26.51%	-16.92%	-97.42%
Return on Common Equity (ROCE)	-54.35%	-74.48%	-81.87%	-96.56%	-136.59%	-138.71%	-122.69%	-49.56%	-67.94%	-19.13%	-104.15%
Return on Equity Simple (ROE_SIMPLE)	-68.79%	0.00%	-115.87%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Net Operating Profit after Tax (NOPAT)	-30	-54	-32	-34	-44	-13	-12	-11	-7.72	-8.79	-30
NOPAT Margin	0.00%	0.00%	0.00%	-1,522.65%	-469.01%	-97.40%	-104.79%	-89.45%	-58.77%	-51.08%	-219.70%
Net Nonoperating Expense Percent (NNEP)	-2.72%	-6.96%	-4.30%	-5.72%	-9.21%	-3.69%	-3.74%	-4.51%	-2.87%	-1.54%	-9.65%
Return On Investment Capital (ROIC_SIMPLE)	-	-30.27%	-18.07%	-24.51%	-52.45%	-19.93%	-21.88%	-24.64%	-8.29%	-3.64%	-14.87%
Cost of Revenue to Revenue	0.00%	0.00%	0.00%	3.89%	8.67%	5.24%	7.38%	5.81%	8.29%	6.63%	7.51%
SG&A Expenses to Revenue	0.00%	0.00%	0.00%	931.49%	139.30%	104.31%	148.19%	140.74%	114.39%	107.94%	182.75%
R&D to Revenue	0.00%	0.00%	0.00%	1,339.84%	622.04%	129.59%	94.13%	81.22%	61.28%	58.39%	223.60%
Operating Expenses to Revenue	0.00%	0.00%	0.00%	2,271.33%	761.34%	233.90%	242.32%	221.97%	175.67%	166.34%	406.34%
Earnings before Interest and Taxes (EBIT)	-39	-74	-43	-47	-61	-18	-16	-15	-10	-11	-41
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)	-41	-68	-43	-47	-60	-17	-16	-14	-10	-11	-41
Valuation Ratios	-	-	-	-	-	-	-	-	-	-	-
Price to Book Value (P/BV)	0.76	2.44	2.97	0.93	1.47	0.78	1.34	2.00	1.42	2.38	1.81
Price to Tangible Book Value (P/TBV)	0.76	2.44	2.97	0.93	1.47	0.78	1.34	2.00	1.42	2.38	1.81
Price to Revenue (P/Rev)	0.00	0.00	0.00	57.97	10.54	2.09	1.98	1.86	2.64	10.78	6.58
Price to Earnings (P/E)	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Dividend Yield	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Earnings Yield	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Enterprise Value to Invested Capital (EV/IC)	0.00	0.00	0.00	0.00	0.00	0.00	4.04	6.45	5.83	23.51	9.70
Enterprise Value to Revenue (EV/Rev)	0.00	0.00	0.00	0.00	1.29	0.00	0.67	1.10	0.94	6.53	3.28
Enterprise Value to EBITDA (EV/EBITDA)	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Enterprise Value to EBIT (EV/EBIT)	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Enterprise Value to NOPAT (EV/NOPAT)	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Enterprise Value to Operating Cash Flow (EV/OCF)	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Enterprise Value to Free Cash Flow (EV/FCFF)	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Leverage & Solvency	-	-	-	-	-	-	-	-	-	-	-
Debt to Equity	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Long-Term Debt to Equity	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Financial Leverage	-1.10	-1.07	-1.03	-1.06	-1.13	-1.10	-1.02	-1.00	-1.09	-0.96	-0.90
Leverage Ratio	1.12	1.15	1.12	1.17	1.33	1.46	1.37	1.45	1.71	1.31	1.34
Compound Leverage Factor	1.12	1.15	1.12	1.17	1.33	1.46	1.37	1.45	1.71	1.31	1.34
Debt to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Short-Term Debt to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Long-Term Debt to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Preferred Equity to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Noncontrolling Interests to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Common Equity to Total Capital	100.00%	100.00%	100.00%	100.00%	100.00%	100.00%	100.00%	100.00%	100.00%	100.00%	100.00%
Debt to EBITDA	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Net Debt to EBITDA	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Long-Term Debt to EBITDA	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Debt to NOPAT	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Net Debt to NOPAT	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Long-Term Debt to NOPAT	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Altman Z-Score	1.18	0.42	3.85	-4.29	-7.34	-9.15	-11.37	-13.37	-7.10	5.93	0.46
Noncontrolling Interest Sharing Ratio	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Liquidity Ratios	-	-	-	-	-	-	-	-	-	-	-
Current Ratio	10.08	4.47	5.77	4.71	1.92	1.62	1.53	1.33	2.47	7.24	6.47
Quick Ratio	9.89	3.99	5.21	4.11	1.46	1.29	1.14	0.98	2.13	7.04	6.18
Cash Flow Metrics	-	-	-	-	-	-	-	-	-	-	-
Free Cash Flow to Firm (FCFF)	-53	-47	-28	-44	-38	-35	-29	-26	-40	-25	-43
Operating Cash Flow to CapEx	0.00%	0.00%	-35,867.14%	0.00%	-821,360.00%	0.00%	-14,672.92%	-120,918.18%	0.00%	0.00%	-5,745.45%
Free Cash Flow to Firm to Interest Expense	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Operating Cash Flow to Interest Expense	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Operating Cash Flow Less CapEx to Interest Expense	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Efficiency Ratios	-	-	-	-	-	-	-	-	-	-	-
Asset Turnover	0.00	0.00	0.00	0.01	0.05	0.14	0.23	0.35	0.33	0.26	0.32
Accounts Receivable Turnover	0.00	0.00	0.00	0.00	0.00	0.00	0.00	7.98	5.56	4.30	5.53
Inventory Turnover	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Fixed Asset Turnover	0.00	0.00	0.00	1.16	6.35	14.91	21.43	29.21	34.51	37.19	34.74
Accounts Payable Turnover	0.00	0.00	0.00	0.02	0.07	0.18	0.50	0.24	0.19	0.31	0.73
Days Sales Outstanding (DSO)	0.00	0.00	0.00	0.00	0.00	0.00	0.00	45.76	65.67	84.80	66.02
Days Inventory Outstanding (DIO)	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Days Payable Outstanding (DPO)	0.00	0.00	0.00	24,079.63	5,486.23	2,075.51	737.37	1,529.31	1,962.03	1,178.29	497.82
Cash Conversion Cycle (CCC)	0.00	0.00	0.00	-24,079.63	-5,486.23	-2,075.51	-737.37	-1,483.56	-1,896.36	-1,093.49	-431.80
Capital & Investment Metrics	-	-	-	-	-	-	-	-	-	-	-
Invested Capital	-18	-23	-11	-7.24	-24	-1.81	6.07	7.88	8.10	15	19
Invested Capital Turnover	0.00	0.00	0.00	-0.19	-0.55	-2.03	-15.23	143.29	-6.41	8.19	4.48
Increase / (Decrease) in Invested Capital	23	-7.15	-4.21	9.63	-5.32	21	17	15	32	17	13
Enterprise Value (EV)	-78	233	340	-17	15	-16	25	51	47	349	183
Market Capitalization	187	434	529	131	122	53	73	86	132	576	367
Book Value per Share	$2.25	$1.61	$1.50	$1.18	$0.70	$0.56	$0.45	$0.36	$0.77	$1.04	$0.72
Tangible Book Value per Share	$2.25	$1.61	$1.50	$1.18	$0.70	$0.56	$0.45	$0.36	$0.77	$1.04	$0.72
Total Capital	246	177	178	141	83	68	54	43	93	242	203
Total Debt	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Total Long-Term Debt	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Net Debt	-265	-201	-189	-148	-107	-69	-48	-35	-85	-227	-184
Capital Expenditures (CapEx)	0.00	0.00	0.14	0.00	0.01	-0.01	0.14	0.01	0.00	0.00	0.73
Debt-free, Cash-free Net Working Capital (DFCFNWC)	-22	-26	-16	-12	-34	-31	-22	-20	-20	-13	-11
Debt-free Net Working Capital (DFNWC)	243	175	174	136	73	39	26	15	65	213	173
Net Working Capital (NWC)	243	175	174	136	73	39	26	15	65	213	173
Net Nonoperating Expense (NNE)	9.30	20	11	13	17	4.98	4.44	4.12	2.75	2.28	11
Net Nonoperating Obligations (NNO)	-265	-201	-189	-148	-107	-69	-48	-35	-85	-227	-184
Total Depreciation and Amortization (D&A)	-1.18	5.65	0.52	0.51	0.56	1.52	0.74	0.50	0.43	0.44	0.51
Debt-free, Cash-free Net Working Capital to Revenue	0.00%	0.00%	0.00%	-511.22%	-296.70%	-120.72%	-59.55%	-43.44%	-39.36%	-25.05%	-19.50%
Debt-free Net Working Capital to Revenue	0.00%	0.00%	0.00%	6,020.63%	627.46%	152.48%	71.49%	32.09%	130.44%	399.25%	310.13%
Net Working Capital to Revenue	0.00%	0.00%	0.00%	6,020.63%	627.46%	152.48%	71.49%	32.09%	130.44%	399.25%	310.13%
Earnings Adjustments	-	-	-	-	-	-	-	-	-	-	-
Adjusted Basic Earnings per Share	($0.36)	($0.67)	($0.38)	($0.40)	($0.51)	($0.14)	($0.14)	($0.12)	($0.06)	$0.02	($0.13)
Adjusted Weighted Average Basic Shares Outstanding	109.75M	109.53M	115.62M	119.36M	119.50M	118.56M	119.88M	120.02M	170.17M	172.21M	309.67M
Adjusted Diluted Earnings per Share	($0.36)	($0.67)	($0.38)	($0.40)	($0.51)	($0.14)	($0.14)	($0.12)	($0.06)	$0.02	($0.13)
Adjusted Weighted Average Diluted Shares Outstanding	109.75M	109.53M	115.62M	119.36M	119.50M	118.56M	119.88M	120.02M	170.17M	172.21M	309.67M
Adjusted Basic & Diluted Earnings per Share	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding	110.11M	119.22M	119.32M	119.44M	119.62M	119.96M	119.96M	120.14M	233.12M	282.59M	294.61M
Normalized Net Operating Profit after Tax (NOPAT)	-30	-54	-32	-34	-44	-13	-12	-11	-7.72	-8.79	-30
Normalized NOPAT Margin	0.00%	0.00%	0.00%	-1,522.65%	-469.01%	-97.40%	-104.79%	-89.45%	-58.77%	-51.08%	-219.70%
Pre Tax Income Margin	0.00%	0.00%	0.00%	-2,086.88%	-653.11%	-133.45%	-144.10%	-124.38%	-79.75%	-64.33%	-301.22%
Debt Service Ratios	-	-	-	-	-	-	-	-	-	-	-
EBIT to Interest Expense	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
NOPAT to Interest Expense	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
EBIT Less CapEx to Interest Expense	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
NOPAT Less CapEx to Interest Expense	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Payout Ratios	-	-	-	-	-	-	-	-	-	-	-
Dividend Payout Ratio	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Augmented Payout Ratio	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%

Financials Breakdown Chart

Invivyd Financials - Frequently Asked Questions

According to the most recent income statement we have on file, Invivyd's financial year ends in December. Their financial year 2025 ended on December 31, 2025.

Invivyd's net income appears to be on a downward trend, with a most recent value of -$52.49 million in 2025, falling from -$226.79 million in 2021. The previous period was -$169.93 million in 2024. View Invivyd's forecast to see where analysts expect Invivyd to go next.

Invivyd's total operating income in 2025 was -$55.56 million, based on the following breakdown:

Total Gross Profit: $49.68 million
Total Operating Expenses: $105.24 million

Over the last 4 years, Invivyd's total revenue changed from $0.00 in 2021 to $53.43 million in 2025, a change of 5,342,600,000.0%.

Invivyd's total liabilities were at $35.34 million at the end of 2025, a 43.0% decrease from 2024, and a 170.1% increase since 2020.

In the past 5 years, Invivyd's cash and equivalents has ranged from $69.35 million in 2024 to $542.22 million in 2021, and is currently $226.69 million as of their latest financial filing in 2025.

Over the last 4 years, Invivyd's book value per share changed from 5.02 in 2021 to 1.04 in 2025, a change of -79.3%.

Related Companies

Financial statements for NASDAQ:IVVD last updated on 7/9/2026 by MarketBeat.com Staff. New filings and market data are monitored continuously.

From Our Partners

Unlock superior investment research and tools.

Get MarketBeat All Access

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Invivyd (IVVD) Financials

Financials Breakdown Chart

Invivyd Financials - Frequently Asked Questions

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Invivyd (IVVD) Financials

Annual Income Statements for Invivyd

Quarterly Income Statements for Invivyd

Annual Cash Flow Statements for Invivyd

Quarterly Cash Flow Statements for Invivyd

Annual Balance Sheets for Invivyd

Quarterly Balance Sheets for Invivyd

Annual Metrics And Ratios for Invivyd

Quarterly Metrics And Ratios for Invivyd

Financials Breakdown Chart

Invivyd Financials - Frequently Asked Questions

When does Invivyd's fiscal year end?

How has Invivyd's net income changed over the last 4 years?

What is Invivyd's operating income?

How has Invivyd's revenue changed over the last 4 years?

How much debt does Invivyd have?

How much cash does Invivyd have?

How has Invivyd's book value per share changed over the last 4 years?

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools